| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Regorafenib |
|---|
| Description | Regorafenib is a multi-kinase inhibitor targeting angiogenic (VEGFR, TIE-2), stromal (PDGFR-β) and oncogenic (RAF, RET and c-KIT) receptor tyrosine kinases, with IC50s of 17, 40 and 69 nM for c-KIT, VEGFR2, B-Raf, respectively. Displays potential antiangiogenic and antineoplastic activities. MW: 482.81. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; BAY 73-4506 |
|---|
| Gene, Accession, CAS # | CAS: 755037-03-7 |
|---|
| Catalog # | 2891-25 |
|---|
| Price | |
|---|
| Order / More Info | Regorafenib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|